Levosert

Levonorgestrel, the active ingredient in Levosert, is a progestogen presented as a 52 mg intrauterine system for intrauterine use. It provides hormonal contraception and can be used to manage heavy menstrual bleeding in women of reproductive age.

GNH USA supplies Levosert as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levosert, a levonorgestrel‑releasing intrauterine system, is indicated for hormonal contraceptive and menstrual‑related indications.

Contraception: provides up to five years of highly effective birth control for women of reproductive age. Heavy menstrual bleeding: reduces menstrual blood loss and improves anemia associated with excessive bleeding.

Levosert may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular bleeding or spotting - Amenorrhea (absence of periods) - Cramping or pelvic pain after insertion - Headache - Breast tenderness - Mood changes

Serious or Rare Side Effects: - Uterine perforation during insertion - Expulsion of the device - Pelvic inflammatory disease - Ectopic pregnancy if contraception fails - Ovarian cyst formation - Severe allergic reaction to device components

Before insertion, clinicians should assess patient suitability and counsel on potential risks. - Confirm non‑pregnancy: verify negative pregnancy test before placement. - Screen for active pelvic infection: avoid insertion in presence of PID or severe cervicitis. - Review uterine anatomy: ensure appropriate cavity size and position. - Counsel on bleeding changes: inform patients about possible spotting or amenorrhea. - Assess contraindications: avoid in women with known levonorgestrel hypersensitivity or liver disease. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levosert may interact with systemic agents that alter steroid metabolism.

Major Interactions (Avoid): - Rifampin and other strong enzyme inducers: may reduce levonorgestrel efficacy. - Certain antiepileptic drugs (e.g., carbamazepine, phenytoin): can lower hormone levels. - Antifungal azoles (e.g., ketoconazole): may increase levonorgestrel concentrations.

Moderate Interactions (Monitor Closely): - St. John's wort: potential reduction in hormone effect, monitor for breakthrough bleeding. - Protease inhibitors used in HIV therapy: may affect levonorgestrel metabolism, consider alternative contraception.